Wall Street Journal report is here: http://online.wsj.com/article/SB122054331213700023.html?mod=djemHL
First few paragraphs:
Tougher Warnings Ordered on Four Drugs
By JARED A. FAVOLE and SHIRLEY S. WANG
September 5, 2008
Federal regulators on Thursday demanded beefed-up warnings on the labels of four big-selling drugs for arthritis and Crohn's disease to alert patients to the risk of serious fungal infections.
The Food and Drug Administration ordered stronger warning labels for Johnson & Johnson's Remicade; Abbott Laboratories' Humira; Enbrel, from Amgen Inc. and Wyeth; and UCB SA's Cimzia. The companies have been cooperating fully with the FDA, said Jeffrey Siegel, leader of the FDA division that regulates arthritis products.
The FDA said it reviewed 240 reports of histoplasmosis, a particularly invasive respiratory disease with symptoms similar to the flu, in patients being treated with Enbrel, Humira, or Remicade. The FDA found one case of the disease in a patient taking Cimzia.
In 21 cases, health professionals didn't recognize the disease, leading to delayed treatment, prolonged hospital stays and death in 12 of the patients involved.
Of the 240 cases, an additional 33 patients whose treatment wasn't delayed also died...